Two diallyl sulphides derived from garlic inhibit meticillin-resistant Staphylococcus aureus infection in diabetic mice

Journal of Medical Microbiology

Volumn 56, Issue 6, 2007, Pages 803-808

  Tsao, Shih Ming ^a   Liu, Wen Hu ^b   Yin, Mei Chin ^b  

^a CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALLYL SULFIDE; ANTITHROMBIN III; C REACTIVE PROTEIN; CEFOTAXIME; DIALLYL DISULFIDE; FIBRINOGEN; FIBRONECTIN; GARLIC EXTRACT; INTERLEUKIN 6; MALONALDEHYDE; METICILLIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; STREPTOZOCIN; TETRACYCLINE; TUMOR NECROSIS FACTOR ALPHA; VANCOMYCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIUM ISOLATE; BAGG ALBINO MOUSE; COLONY FORMING UNIT; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; GARLIC; INFECTION PREVENTION; KIDNEY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN BLOOD LEVEL; SPLEEN; STAPHYLOCOCCUS INFECTION;

ALLYL COMPOUNDS; ANIMALS; ANTI-BACTERIAL AGENTS; ANTITHROMBIN III; C-REACTIVE PROTEIN; COLONY COUNT, MICROBIAL; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DISULFIDES; FIBRINOGEN; FIBRONECTINS; GARLIC; HUMANS; KIDNEY; MALE; MALONDIALDEHYDE; METHICILLIN RESISTANCE; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; SPLEEN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; STREPTOZOCIN; SULFIDES;

EID: 34250366657     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.46998-0     Document Type: Article

References (20)

1. Asakawa, H., Tokunaga, K. & Kawakami, F. (2000). Elevation of fibrinogen and thrombin-antithrombin III complex levels of type 2 diabetes mellitus patients with retinopathy and nephropathy. J Diabetes Complications 14, 121-126.
2. Chang, S. C., Hsieh, W. C. & Liu, C. (2000). High prevalence of antibiotic resistance of common pathogenic bacteria in Taiwan. Diagn Microbiol Infect Dis 36, 107-112.
3. Cossart, P. (1997). Host/pathogen interactions: subversion of the mammalian cell cytoskeleton by invasive bacteria. J Clin Invest 99, 2307-2311.
4. Hanaki, H., Akagi, H., Masaru, Y., Otani, T., Hyodo, A. & Hiramatsu, K. (1995). TOC-39, a novel parenteral broad-spectrum cephalosporin with excellent activity against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 39, 1120-1126.
5. Hiramatsu, K., Hanaki, H. & Ino, T. (1997). Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40, 135-136.
6. Jain, S. K. & Palmer, M. (1997). The effect of oxygen radical metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 22, 593-596.
7. Jang, T. N., Kuo, B. I. & Shen, S. H. (1999). Nosocomial Gram-negative bacteria in critically ill patients: epidemiologic characteristics and prognostic factors in 147 episodes. J Formos Med Assoc 98, 465-473.
8. Lowy, F. D. (1998). Staphylococcus aureus infections. N Engl J Med 339, 520-532.
9. McCarty, M. F. (1999). Interleukin-6 as a central mediator of cardiovascular risk associated with chronic inflammation, smoking, diabetes and visceral obesity: down-regulation with essential fatty acids, ethanol and pentoxifylline. Med Hypotheses 52, 465-477.
10. Mohamed-Ali, V., Armstrong, L., Vlark, D., Bolton, C. H. & Pinkney, J. H. (2001). Evidence for the regulation of levels of plasma adhesion molecules by inflammatory cytokines and their soluble receptors in type 1 diabetes. J Intern Med 250, 415-421.
11. Muller, A., Schott-Ohly, P. & Dohle, C. (2002). Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin. Immunobiology 205, 35-50.
12. NCCLS (1999). Performance Standards for Antimicrobial Susceptibility Testing, 9th informational supplement. Approved standard M100-S9. Villanova, PA: National Committee for Clinical Laboratory Standards.
13. Sakata, N., Meng, J. & Takebayashi, S. (2000). Effects of advanced glycation end products on the proliferation and fibronectin production of smooth muscle cells. J Atheroscler Thromb 7, 169-176.
14. SAS (1990). SAS User's Guide: Statistics. Cary, NC: SAS Institute.
15. Shimada, A., Charlton, B., Rohane, P., Taylor-Edwards, C. & Fathman, C. G. (1996). Immune regulation in type I diabetes. J Autoimmun 9, 263-269.
16. Tomita, M., Dragoman, M., Worcester, H., Conran, P. & Santoro, T. J. (2004). Proinflammatory cytokine genes are constitutively overexpressed in the heart in experimental systemic lupus erythematosus: a brief communication. Exp Biol Med (Maywood) 229, 971-976.
17. Tsao, S. M., Hsu, C. C. & Yin, M. C. (2003). Garlic extract and two diallyl sulphides inhibit methicillin-resistant Staphylococcus aureus infection in BALB/cA mice. J Antimicrob Chemother 52, 974-980.
18. Tsao, S. M., Hsu, C. C. & Yin, M. C. (2006). Meticillin-resistant Staphylococcus aureus infection in diabetic mice enhanced inflammation and coagulation. J Med Microbiol 55, 379-385.
19. Wu, C. C., Sheen, L. Y., Chen, H. W., Tsai, S. J. & Lii, C. K. (2001). Effects of organosulfur compounds from garlic oil on the antioxidation system in rat liver and red blood cells. Food Chcm Toxicol 39, 563-569.
20. Yin, M. C., Hwang, S. W. & Chan, K. C. (2002). Nonenzymatic antioxidant activity of four organosulfur compounds derived from garlic. J Agric Food Chem 50, 6143-6147.